Global Media Strategies -- Your Brand, Your Audience

Aldagen Presents Data Describing Cell Therapy Products’ Mechanism for Homing to Ischemic Injury

January 27, 2012 By: NCTechNews Category: Biopharmaceutical

(Durham, N.C.) Aldagen, Inc. today announced that a poster describing the homing properties of its cellular therapies was presented at the Seventh International Conference on Cell Therapy for Cardiovascular Disease. The data further explains the mechanism of action for Aldagen’s cell therapy products, and supports the ability of these cells to home to the site of ischemic injury.

The poster, entitled Mechanisms of Homing of Bone Marrow Derived ALDHbr Stem Cells to Ischemic Injury, describes the multiple mechanisms by which Aldagen’s cell therapy products home to areas of ischemic damage. These mechanisms include the expression of integrins and selectins that can bind to the endothelium and promote transmigration into ischemic tissues.

“This scientific poster provides evidence that our cellular products home to sites of ischemic damage, and give us a better understanding of the mechanisms behind this action. These data, along with the recently published paper describing the pro-angiogenic activity of our cellular therapies, outlines a compelling mechanism of action for our cell products, and supports the potential of our ongoing clinical programs,” said Lyle A. Hohnke, Ph.D., Chief Executive Officer of Aldagen.

About Aldagen
Aldagen is a clinical-stage biopharmaceutical company developing proprietary regenerative cell therapies. Our product candidates consist of a specific population of a patient’s own stem cells, which are isolated using our proprietary technology and which we believe have the potential to promote the regeneration of multiple types of cells and tissues, including the growth of new blood vessels. Our initial focus is on developing product candidates to address cardiovascular disease. Our clinical stage cardiovascular product candidates are ALD-301 for the treatment of critical limb ischemia, ALD-201 for the treatment of ischemic heart failure, and ALD-401 for the post-acute treatment of ischemic stroke.

Comments are closed.

← New Analysis Shows Lower Mortality Rates and Less Need for Redosing
North Carolina Officially Launches the First Commercial TV White Spaces Network →

  • Packaging Cures
    RTP-based advertising and branding firm The Marketing Machine helped overcome the issue of illiteracy among medical patients in Ghana, South Africa in designing packaging for the only manufacturer of anti-retroviral drugs in the region, creating individual icons and colors to help patients understand which drugs they needed, regardless of their ability to read.

    Broadband Stimulus
    Two grants funded by the American Recovery and Reinvestment Act are being used by MCNC to expand broadband connectivity and services throughout North Carolina and create more than 1,000 engineering and construction jobs, the organization said.

    Video: QC in Pharma Mfg


    Defense Industry Gets More Competitive
    U.S. troop level decreases and shrinking armed forces budgets will lead to increased competition and a change in business operations for military contractors in North Carolina and throughout the nation, according to defense industry contracting expert Lea Strickland, requiring a more strategic and tactical approach to developing professional, properly-designed bid proposals.

    A Leg Up for Students
    Innovative concept-to-marketplace product design and development firm Montie Design is holding a Winter 2012 Student Design Contest for aspiring product designers in community colleges, four-year colleges, or high schools from North Carolina and Virginia, starting February 1.

    getting from lab 2 line
    The leader in analytical instrumentation for the pharma manufacturing industry has named a new COO responsible for manufacturing, engineering, software development, and project management for hardware and software products such as the VTT-1000 multi-variant testing device, breaking down barriers to speeding-up the drug manufacturing pipeline and cutting-down on drug shortages.

  • Recent Headlines

















free web site traffic and promotion